SEC Form 4 · accession 0001437749-16-037297
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary T Steele
Director
Period of report
Aug 11, 2016
Accepted (ET)
Aug 12, 2016 · 2:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 11, 2016 | S | 34,484 | $12.466 | D | 65,102 | I | Held in Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.41 to $12.505, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.